InvestmentJun 22, 2026, 04:17 PM
CervoMed Closes $10M Registered Direct Offering at $4.00/Share
AI Summary
CervoMed Inc. announced the closing of its previously announced registered direct offering on June 22, 2026. The company sold 2,500,000 shares of common stock at a purchase price of $4.00 per share, resulting in gross proceeds of $10 million. The net proceeds from the offering are intended for working capital and general corporate purposes.
Key Highlights
- Closed registered direct offering on June 22, 2026.
- Sold 2,500,000 shares of common stock.
- Purchase price of $4.00 per share.
- Generated gross proceeds of $10 million.
- Net proceeds to be used for working capital and general corporate purposes.
- H.C. Wainwright & Co. served as the exclusive placement agent.
Price Impact
More from CRVO